Clinical Trials Logo

Collagenous Colitis clinical trials

View clinical trials related to Collagenous Colitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT03658993 Not yet recruiting - Collagenous Colitis Clinical Trials

Rifaximin-treatment of Collagenous Colitis

XiCoCo
Start date: November 1, 2018
Phase: Phase 3
Study type: Interventional

The hypothesis of this study is that an altered gut microbiota is a contributory factor in initiating an inflammatory process in the colonic mucosa leading to collagenous colitis. The investigators suggest that treatment with budesonide reduces the inflammation without treating the underlying cause. In this trial the investigators will try to modullate gut microbiota by adding rifaximin. The aim of this study is to assess if 4 weeks treatment with rifaximin as a supplement to a standard course of budesonide against active CC can reduce the risk of relapse after treatment cessation.

NCT ID: NCT01928667 Completed - Microscopic Colitis Clinical Trials

Case-Control Study to Identify Risk Factors for Microscopic Colitis

Start date: July 2014
Phase: N/A
Study type: Observational

The purpose of the study is to assess among others environmental and hygiene-related risk factors for microscopic colitis (MC), a common diarrheal disease.

NCT ID: NCT01504048 Recruiting - Collagenous Colitis Clinical Trials

Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis

Start date: June 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether chromoendoscopy using Indigo-Carmine dye spray is useful in diagnosing microscopic colitis among patients undergoing colonoscopy due to chronic watery diarrhea.

NCT ID: NCT00450086 Completed - Collagenous Colitis Clinical Trials

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis

Start date: March 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of collagenous colitis.

NCT ID: NCT00180076 Completed - Collagenous Colitis Clinical Trials

Budesonide for Maintenance Treatment of Collagenous Colitis

Start date: July 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether orale budesonide is effective in maintaining clinical remission in patients with collagenous colitis.

NCT ID: NCT00139165 Active, not recruiting - Collagenous Colitis Clinical Trials

Long-Term Treatment of Collagenous Colitis With Budesonide

Start date: September 2004
Phase: Phase 3
Study type: Interventional

The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with placebo or continued budesonide. The end poit is effect on clinical symptoms (number of daily stools)